MS2734
MS2734 is a dual-substrate NNMT inhibitor that acts as a SAM (HY-B0617) competitor and a non-competitor of Nicotinamide (HY-B0150), with an IC50 of 14 μM and a Kd of 2.7 μM against hNNMT. MS2734 inhibits the methyltransferase activities of DOT1L (IC50 1.3 μM), PRMT7 (IC50 20 μM), BCDIN3D (IC50 40 μM) and SMYD2 (IC50 62 μM). MS2734 is applicable to research related to diabetes, obesity and various cancers.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2587612-25-5
- Formule: C24H32N8O6
- Masse moléculaire:528.56
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Voir tous les produits spécifiques à Isoform Histone Methyltransferase
More
Activité biologique
|
NNMT 14 μM (IC50) |
DOT1L 1.3 μM (IC50) |
PRMT7 20 μM (IC50) |
SMYD2 62 μM (IC50) |
BCDIN3D 40 μM (IC50) |
MS2734 (250 nM-250 μM) inhibits the methyltransferase activity of purified hNNMT in the SAHH-coupled fluorescence assay, with an IC50 of 14 μM[1].
MS2734 binds directly to purified hNNMT, with a Kd value of 2.7 μM measured by ITC[1].
MS2734 exhibits better selectivity for hNNMT than most tested methyltransferases and acetyltransferases, and shows significant inhibitory effects on DOT1L (IC50 = 1.3 μM), PRMT7 (IC50 = 20 μM), BCDIN3D (IC50 = 40 μM) and SMYD2 (IC50 = 62 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2587612-25-5
-
Masse moléculaire 528.56
-
Formule C24H32N8O6
-
SMILES
O[C@@H]1[C@H](O)[C@@H](CN(CCC[C@H](N)C(O)=O)CCC2=CC(C(N)=O)=CC=C2)O[C@H]1N3C=NC4=C(N)N=CN=C43
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Babault N, et al. Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT). J Med Chem. 2018 Feb 22;61(4):1541-1551. doi: 10.1021/acs.jmedchem.7b01422. Epub 2018 Jan 31. Erratum in: J Med Chem. 2018 Jul 12;61(13):5771-5772. [Content Brief]
[2]. Policarpo RL, et al. High-Affinity Alkynyl Bisubstrate Inhibitors of Nicotinamide -Methyltransferase (NNMT). Journal of medicinal chemistry. 2019 Nov 14;62(21):9837-9873. [Content Brief]
[3]. Li XY, et al. Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy. Frontiers in oncology. 2022;12:894744. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
MS2734 Related Classifications
HY-111367 Related Classifications
Powered by Bioz